Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 2;22(1):1250.
doi: 10.1186/s12885-022-10315-x.

Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer

Affiliations

Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer

Xinhong Liang et al. BMC Cancer. .

Abstract

Introduction: Improving the early prediction of neoadjuvant chemotherapy (NAC) efficacy in breast cancer can lead to an improved prediction of the final prognosis of patients, which would be useful for promoting individualized treatment. This study aimed to explore the value of the combination of dynamic contrast-enhanced (DCE)-MRI parameters and apparent diffusion coefficient (ADC) values in the early prediction of pathological complete response (pCR) to NAC for breast cancer.

Methods: A total of 119 (range, 28-69 years) patients with biopsy-proven breast cancer who received two cycles of NAC before breast surgery were retrospectively enrolled from our hospital database. Patients were divided into pCR and non pCR groups according to their pathological responses; a total of 24 patients achieved pCR, while 95 did not. The quantitative (Ktrans; Kep; Ve; IAUC) and semiquantitative parameters (W-in; W-out; TTP) of DCE-MRI that were significantly different between groups were combined with ADC values to explore their value in the early prediction of pCR to NAC for breast cancer. The independent T test was performed to compare the differences in DCE-MRI parameters and ADC values between the two groups. Receiver operating characteristic (ROC) curves were plotted, and the area under the ROC curve (AUC), sensitivity and specificity were calculated to evaluate the performance of the prediction.

Results: The Ktrans, Kep, IAUC, ADC, W-in and TTP values were significantly different between the pCR and non pCR groups after NAC. The AUC (0.845) and specificity (95.79%) of the combined Ktrans, Kep, IAUC and ADC values were both higher than those of the individual parameters. The combination of W-in, TTP and ADC values had the highest AUC value (0.886) in predicting pCR, with a sensitivity and specificity of 87.5% and 82.11%, respectively.

Conclusions: The results suggested that the combination of ADC values and quantitative and semiquantitative DCE-MRI parameters, especially the combination of W-in, TTP, and ADC values, may improve the early prediction of pCR in breast cancer.

Keywords: DCE-MRI; Neoadjuvant chemotherapy; apparent diffusion coefficient values; breast cancer; treatment response.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
MR images of a 65-year-old woman with invasive ductal carcinoma of the left breast before NAC. A TWIST-DCE image. BH Pseudocolor images for determining Ktrans (B), Kep (C), IAUC (D), W-in (E), W-out (F), TTP (G), and ADC (H). Red represents high values, yellow intermediate values, and blue low values. The values for Ktrans, Kep, IAUC, W-in, W-out, and TTP were 0.309 min-1, 1.136 min-1, 0.336, 0.499 min-1, 0.013 min-1, 0.582 minutes and 0.849×10-3 mm2/s, respectively
Fig. 2
Fig. 2
MR images of the same patient after two cycles of NAC. The patient underwent surgery after six cycles of NAC. Surgical specimens indicated a complete response (Miller-Payne grade 5). A TWIST-DCE image. BH Pseudocolor images for Ktrans (B), Kep (C), IAUC (D), W-in (E), W-out (F), TTP (G), and ADC (H). Red represents high values, yellow intermediate values, and blue low values. The values for Ktrans, Kep, IAUC, W-in, W-out, and TTP were 0.069 min-1, 0.339 min-1, 0.083, 0.181 min-1, 0.022 min-1, 0.868 minutes and 1.036×10-3 mm 2/s, respectively
Fig. 3
Fig. 3
Box plot graphs revealing statistically significant differences in values between CR and non pCR groups
Fig. 4
Fig. 4
ROC curves of DCE-MRI quantitative parameters, ADC value, and combination of multiple parameters in predicting pCR after two cycles of NAC
Fig. 5
Fig. 5
ROC curves of DCE-MRI semiquantitative parameters, ADC values and combinations of multiple parameters in predicting pCR after NAC
Fig. 6
Fig. 6
The nomogram to predict pCR with quantitative DCE- MRI parameters and ADC values after two cycles of NAC for breast cancer patients

Similar articles

Cited by

References

    1. Ryu JM, Lee SK, Kim JY, Yu J, Kim SW, Lee JE, Han SH, Jung YS, Nam SJ. Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis. Clinical breast cancer. 2017;17(7):550–558. doi: 10.1016/j.clbc.2017.03.014. - DOI - PubMed
    1. Yang Z, Chen X, Zhang T, Cheng F, Liao Y, Chen X, Dai Z, Fan W. Quantitative Multiparametric MRI as an Imaging Biomarker for the Prediction of Breast Cancer Receptor Status and Molecular Subtypes. Frontiers in oncology. 2021;11:628824. doi: 10.3389/fonc.2021.628824. - DOI - PMC - PubMed
    1. Chen X, Chen X, Yang J, Li Y, Fan W, Yang Z. Combining Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Apparent Diffusion Coefficient Maps for a Radiomics Nomogram to Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients. J Comput Assist Tomogr. 2020;44(2):275–283. doi: 10.1097/RCT.0000000000000978. - DOI - PubMed
    1. Fowler AM, Mankoff DA, Joe BN. Imaging Neoadjuvant Therapy Response in Breast Cancer. Radiology. 2017;285(2):358–375. doi: 10.1148/radiol.2017170180. - DOI - PubMed
    1. Dong JM, Wang HX, Zhong XF, Xu K, Bian J, Feng Y, Chen L, Zhang L, Wang X, Ma DJ, et al. Changes in background parenchymal enhancement in HER2-positive breast cancer before and after neoadjuvant chemotherapy: Association with pathologic complete response. Medicine (Baltimore) 2018;97(43):e12965. doi: 10.1097/MD.0000000000012965. - DOI - PMC - PubMed